1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Carcinoma, Breast: new trials by email Literature Review of Carcinoma, Breast trials Research Report on Carcinoma, Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) Neoadjuvant endocrine therapy - Breast Cancer Stage I, Breast Cancer Stage II | Phase 2 | Recruiting | George Washington University | 90 | 2024-10-01 | 2026-03-03 |
| CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer 0.04 mg/kg CpG 7909, Herceptin®, 0.08 mg/kg CpG 7909 - Carcinoma, Breast | Phase 2 | Completed | Pfizer | 16 | 2002-09-01 | 2009-03-12 |
Breast Neoplasms (2) · Carcinoma (1) · Neoplasms (1)
Breast Diseases (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
ProMune (1) · Trastuzumab (1)
George Washington University (1) · Pfizer (1)
United States (2)